76 percent of patients on oral JAK1/JAK2 inhibitor plus DMARDS achieve ACR20 response at week 12
Baricitinib demonstrates dose-dependent efficacy in active RA
2012-06-08
(Press-News.org) Berlin, Germany, June 8 2012: Data from a Phase IIb study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, show that 76% of patients with active rheumatoid arthritis (RA) receiving either 4mg or 8mg of baricitinib, an oral JAK1/JAK2 inhibitor, plus stable methotrexate (MTX) achieved ACR20* response compared with 41% of placebo-treated patients (p≤0.001) at 12 weeks. The 4mg and 8mg doses of baricitinib demonstrated statistical superiority to placebo in all clinical outcomes measured, including ACR20/50/70*, DAS28**-CRP and DAS28-CRP END
ELSE PRESS RELEASES FROM THIS DATE:
Novel brain imaging technique explains why concussions affect people differently
2012-06-08
June 8, 2012 — (Bronx, NY) — Patients vary widely in their response to concussion, but scientists haven't understood why. Now, using a new technique for analyzing data from brain imaging studies, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that concussion victims have unique spatial patterns of brain abnormalities that change over time.
The new technique could eventually help in assessing concussion patients, predicting which head injuries are likely to have long-lasting neurological consequences, ...
Smoking negatively affects response to anti-TNF treatment in patients with rheumatoid arthritis
2012-06-08
Berlin, Germany, June 8 2012: A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, reinforces current thinking that smoking negatively affects treatment response in rheumatoid arthritis (RA) patients treated with anti-tumour necrosis factor (anti-TNF) drugs.
This American study, the largest of its kind, followed 2,811 treatment naïve patients initiated onto anti-TNF therapy. Of the study group, 19% (n=521) were smokers and 81% (n=2,290) were non-smokers. Smokers had significantly higher scores on the Clinical Disease ...
Lung changes are present in nearly half of ACPA positive RA patients at disease onset
2012-06-08
Berlin, Germany, June 8 2012: A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that lung changes in association with anti-citrullinated protein autoantibody (ACPA) status are a primary manifestation of rheumatoid arthritis (RA).
Study findings show that 51% of RA patients (n=105) had identifiable lung changes (as measured by high resolution computer tomography [HRCT]) as compared to 28% of healthy controls (n=43). In addition, ACPA presence – but not smoking status – was associated with HRCT changes. This ...
Obesity negatively predicts minimal disease activity achievement in patients with PSA
2012-06-08
Berlin, Germany, June 8 2012: According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with psoriatic arthritis (PsA) who are starting anti-tumour necrosis factor (anti-TNF) treatment and adhere to a hypocaloric diet have a significantly greater chance of achieving minimal disease activity (MDA, an important measure of disease activity) at six months compared to those on a standard diet.
The results of an Italian study of 138 obese PsA patients demonstrated that those who achieved a ≥10% weight ...
Patients with PsA treated with ustekinumab are twice as likely to achieve acr20 vs. placebo
2012-06-08
Berlin, Germany, June 8 2012: A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients with active psoriatic arthritis (PsA) treated with Ustekinumab (UST) 90mg were more than twice as likely to achieve the study's primary endpoint, ACR20* at 24 weeks, than those treated with placebo (49.5% vs 22.8%). 42.4% of patients treated with UST 45mg were also more likely to achieve ACR20 at 24 weeks compared to placebo.
Significant improvements were also seen with UST 45mg and 90mg in ACR50* (24.9% ...
Early menopause predicts a milder form of rheumatoid arthritis
2012-06-08
Berlin, Germany, June 8 2012 : A new study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that early menopause predicts a milder form of rheumatoid arthritis (RA). New insights on factors influencing RA are good news for sufferers of the chronic inflammatory disease that currently affects over 2 million women in Europe. 1,2
The study, based on 134 incident RA cases, found that patients aged over 45 years with a history of early menopause were 50% less likely to develop severe RA (16% versus 35%) and more likely to develop ...
Rabbit risk score can help rheumatologists identify patients at high risk of infection
2012-06-08
Berlin, Germany, June 8 2012: Results of a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, suggest that the newly developed RABBIT Risk Score, which calculates the risk of serious infections in patients with rheumatoid arthritis (RA) who are treated with anti-tumour necrosis factor drugs (anti-TNFs) or conventional disease modifying anti-rheumatic drugs (DMARDs) is a valid and effective tool for rheumatologists to predict risk of serious infection.
The German study used data from 2,603 patients enrolled in the RABBIT ...
13.7 million young adults stayed on or joined their parents' health plans in 2011
2012-06-08
June 8, 2012, New York, NY—In 2011, 13.7 million young adults ages 19 to 25 stayed on or joined their parents' health plans, including 6.6 million who would likely not have been able to do so before passage of the Affordable Care Act, according to a new Commonwealth Fund report.
However, not all young adults have parents with health plans they can join, and many still experience gaps in coverage and face medical bill problems and medical debt. Nearly two of five (39%) young adults ages 19 to 29 went without health insurance at some time in 2011, and more than one-third ...
Parcel2Go Helping Small Businesses to Beat Royal Mail Price Increase
2012-06-08
Small firms feeling the squeeze following the Royal Mail's decision to increase the price of first and second class stamps at the end of last month are being offered a helping hand by Bolton-based online parcel delivery firm Parcel2Go.
The company says businesses and individuals can try to beat the Royal Mail price increase by becoming Parcel2Go users and benefiting from the vast range of reliable and cost-effective UK express delivery solutions available through the website.
With just a few clicks of a mouse, customers can order delivery services from some of the ...
King Jackpot Makes Playing No Deposit Bingo a Breeze
2012-06-08
Any experienced bingo player can tell you that one of the keys to success in playing bingo online is choosing the right bingo website. Many bingo websites are all talk and no show, or do not give players the generous offers that they desire and deserve. One feature on bingo websites that every new player should look out for is no deposit required bingo.
This means that when players register, they are given free cash to be used towards trying bingo games on the website, without spending a penny of their own money! While players cannot withdraw this cash for personal ...
LAST 30 PRESS RELEASES:
Effectiveness and cost-effectiveness of automated external defibrillators in private homes
University of Phoenix College of Social and Behavioral Sciences leadership publishes white paper on trauma-informed education
Microbial iron mining: turning polluted soils into self-cleaning reactors
Molecular snapshots reveal how the body knows it’s too hot
Analysis finds alarming rise in severe diverticulitis among younger Americans
Mitochondria and lysosomes reprogram immune cells that dampen inflammation
Cockroach infestation linked to home allergen, endotoxin levels
New biochar-powered microbial systems offer sustainable solution for toxic pollutants
Identifying the best high-biomass sorghum hybrids based on biomass yield potential and feedstock quality affected by nitrogen fertility management under various environments
How HIV’s shape-shifting protein reveals clues for smarter drug design
Study identifies viral combinations that heighten risk of severe respiratory illnesses in infants
Aboveground rather than belowground productivity drives variability in miscanthus × giganteus net primary productivity
Making yeast more efficient 'cell factories' for producing valuable plant compounds
Aging in plain sight: What new research says the eyes reveal about aging and cardiovascular risk
Child welfare system involvement may improve diagnosis of developmental delays
Heavier electric trucks could strain New York City’s roads and bridges, study warns
From womb to world: scientists reveal how maternal stress programs infant development
Bezos Earth Fund grants $2M to UC Davis and American Heart Association to advance AI-designed foods
Data Protection is transforming humanitarian action in the digital age, new book shows
AI unlocks the microscopic world to transform future manufacturing
Virtual reality helps people understand and care about distant communities
Optica Publishing Group announces subscribe to open pilot for the Journal of the Optical Society of America B (JOSA B)
UNF partners with Korey Stringer Institute and Perry Weather to open heat exercise laboratory on campus
DNA from Napoleon’s 1812 army identifies the pathogens likely responsible for the army’s demise during their retreat from Russia
Study suggests two unsuspected pathogens struck Napoleon's army during the retreat from Russia in 1812
The 25-year incidence and progression of hearing loss in the Framingham offspring study
AI-driven nanomedicine breakthrough paves way for personalized breast cancer therapy
Fight or flight—and grow a new limb
Augmenting electroencephalogram transformer for steady-state visually evoked potential-based brain–computer interfaces
Coaches can boost athletes’ mental toughness with this leadership style
[Press-News.org] 76 percent of patients on oral JAK1/JAK2 inhibitor plus DMARDS achieve ACR20 response at week 12Baricitinib demonstrates dose-dependent efficacy in active RA